Merck acquires Acceleron Pharma for $11.5bn
Merck (MSD) has agreed to buy Acceleron Pharma’s outstanding shares for $180 in cash per share and a total equity…
clinical trials
Ryvu Therapeutics has reported a PLN 24.24m net loss from continuing operations
According to a company report, Ryvu Therapeutics recorded a PLN 24.24m standalone net loss from continuing operations in the second…
Vatnak Vat-Ho as Chief Business Officer at Ryvu Therapeutics
Ryvu Therapeutics S.A., one of Europe’s largest innovative biotechnology companies active in the discovery and development of new oncology therapies,…
Neuca Group to invest PLN 60m
Neuca Group, one of the largest pharmaceutical distributors in Poland, plans to invest in 2021 PLN 60m. This information was…
Pfizer tests the world’s first anti COVID-19 pill
Pfizer is launching a phase 1 trial of a new oral antiviral drug against SARS-COV-2. The drug for COVID-19 in…
Neuca to appoint new vice-president
Krzysztof Miszewski has become the new vice-president of Neuca, the company announced in a statement. He will be responsible for…
Pratia of Neuca Group invests in Bulgaria
Pratia, a Neuca Group company with over 90 dedicated and hospital-based research centers in six countries, has invested in the…
MSD: Dimitri Gitas from Greece to Poland
Dimitri Gitas has been appointed Managing Director of the Polish branch of biopharmaceutical company MSD Poland as of 1 February…
Neuca: another company in the group’s portfolio
Neuca is not slowing down and is making another acquisition in the area of clinical trials. This time, it is…
Bayer will acquire Asklepios BioPharmaceutical (AskBio)
Bayer AG has announced its intention to acquire a biopharmaceutical company based in the USA. Asklepios BioPharmaceutical, Inc. (AskBio) will…
